Dr. Felix Kratz und Albumin - Info zur Person

(1 - 10 von 14

)

CytRx Unveils Novel LADR™ (Linker Activated Drug Release) Technology...

www.prnewswire.com

... that are attached to either albumin or anti-cancer antibodies," stated Dr. Felix Kratz, Vice President of Drug Discovery at CytRx. "These ...

CytRx Nominates Next Clinical Drug Candidate DK049

ih.advfn.com

... linker-controlled drug release to be used with both antibody-drug conjugates and albumin-binding approaches, " commented Dr. Felix Kratz, ...

CytRx Launches Discovery Laboratory to Develop Albumin-Binding...

www.prnewswire.com

Dr. Felix Kratz, one of the most highly regarded conjugation chemists in oncology, joins CytRx with 25 years of experience in drug discovery and research. Dr. Kratz's research includes the development of novel, targeted molecules for cancer therapies, with a special emphasis on the use of albumin as a ...

CytRx Corporation Leads Revival of Cytotoxic Therapies with LADR™...

www.prnewswire.com

The manuscript was published by Felix Kratz, PhD and his team of researchers who have been pioneers in the field of albumin-based drug ...

WITHDRAWN: A clinical update of using albumin as a drug vehicle — A...

www.sciencedirect.com

WITHDRAWN: A clinical update of using albumin as a drug vehicle â€” A commentary Felix Kratz Tumor Biology CenterD

Archiv | Fachbereich Chemie, Pharmazie, Geographie und...

www.fb09.uni-mainz.de

: Max Planck Graduate Center mit der Johannes Gutenberg-Universität Mainz. Dr. Felix Kratz, Tumor Biology Center Freiburg Albumin, a versatile drug carrier: The Past, Present and Future , 16:30-18:00, C04/05, Hörsaalgebäude Chemie : DNA-Analysen belegen ...

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Dr. Felix Kratz und Albumin Person-Info

CytRx Unveils Novel LADR™ (Linker Activated Drug Release) Technology...

CytRx Nominates Next Clinical Drug Candidate DK049

CytRx Launches Discovery Laboratory to Develop Albumin-Binding...

CytRx Corporation Leads Revival of Cytotoxic Therapies with LADR™...

WITHDRAWN: A clinical update of using albumin as a drug vehicle — A...

Archiv | Fachbereich Chemie, Pharmazie, Geographie und...

CytRx Corporation to Present Breakthrough Data on Albumin Binding ...

Krebstherapie: Drug Targeting mit Albumin

CytRx Corporation Launches Discovery Laboratory To Develop...

the peptide or protein in the drug conjugate being an albumin | TREA

Alle Infos zum Namen "Dr. Felix Kratz"